• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday

    9/19/22 1:53:09 AM ET
    $AAOI
    $ACET
    $ADTX
    $AIMD
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAOI alert in real time by email

    Gainers

    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares jumped 53% to close at $0.58 on Friday.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million.
    • iBio, Inc. (NYSE:IBIO) gained 49.8% to close at $0.46.
    • Armata Pharmaceuticals, Inc. (NYSE:ARMP) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share.
    • Axcella Health Inc. (NASDAQ:AXLA) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share.
    • Anixa Biosciences, Inc. (NASDAQ:ANIX) gained 27.5% to close at $5.71.
    • Lannett Company, Inc. (NYSE:LCI) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago
    • Integrated Media Technology Limited (NASDAQ:IMTE) climbed 21.5% to close at $1.75.
    • Decisionpoint Systems, Inc. (NASDAQ:DPSI) rose 20.8% to close at $5.93.
    • TMC the metals company Inc. (NASDAQ:TMC) gained 20.2% to close at $1.25.
    • Dawson Geophysical Company (NASDAQ:DWSN) surged 19.1% to close at $2.00.
    • Nano Labs Ltd (NASDAQ:NA) jumped 18.8% to close at $5.56.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) climbed 18.5% to close at $2.50 after dropping 38% on Thursday.
    • Palatin Technologies, Inc. (NYSE:PTN) rose 18.3% to close at $7.96.
    • Palatin Technologies recently announced the initiation of patient recruitment for its Phase 2 study evaluating oral PL8177 in ulcerative colitis.
    • Enzo Biochem, Inc. (NYSE:ENZ) gained 18.1% to settle at $2.67.
    • BayFirst Financial Corp. (NASDAQ:BAFN) surged 18% to close at $21.65.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) gained 17.2% to close at $1.50.
    • Studio City International Holdings Limited (NYSE:MSC) rose 16.9% to close at $1.80.
    • Forian Inc. (NASDAQ:FORA) gained 16.5% to close at $4.10.
    • Digital Ally, Inc. (NASDAQ:DGLY) jumped 15.5% to settle at $0.62.
    • SoundHound AI, Inc. (NASDAQ:SOUN) rose 15.1% to close at $3.74.
    • Intrusion Inc. (NASDAQ:INTZ) gained 14.4% to close at $5.01.
    • Emclaire Financial Corp (NASDAQ:EMCF) rose 13.6% to close at $36.50.
    • Velocity Financial, Inc. (NYSE:VEL) gained 10.7% to close at $13.00.
    • Azure Power Global Limited (NYSE:AZRE) rose 10.2% to settle at $5.97.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) jumped 9.1% to close at $6.09.
    • Gogo Inc. (NASDAQ:GOGO) jumped 8.9% to close at $13.32.
    • Harmonic Inc. (NASDAQ:HLIT) gained 6.1% to close at $11.88. Needham maintained Harmonic with a Buy and raised the price target from $15 to $17.
    • JanOne Inc. (NASDAQ:JAN) shares gained 4.6% to close at $2.49. The company executed a term sheet to acquire Soin Therapeutics LLC and its product, a patent-pending, novel formulation of low dose naltrexone.


    Losers

    • Aditxt, Inc. (NASDAQ:ADTX) shares dipped 58.5% to close at $4.31 on Friday after the company announced pricing of $20 million public offering of $6 per share. Dawson James downgraded Aditxt from Buy to Neutral.
    • FOXO Technologies Inc. (NYSE:FOXO) shares fell 52.1% to close at $4.02.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) declined 46.2% to close at $0.1750 after the company reported pricing of $7.5 million public offering of common stock and warrants.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) fell 45.9% to close at $8.99.
    • Nabriva Therapeutics plc (NASDAQ:NBRV) declined 43.4% to settle at $3.82 following effect of 1:25 reverse stock split.
    • Scienjoy Holding Corporation (NASDAQ:SJ) declined 38.6% to close at $3.07. Scienjoy Holding recently posted Q2 sales of $75.60 million.
    • Getty Images Holdings, Inc. (NYSE:GETY) dropped 36.4% to close at $8.49.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) fell 30.5% to close at $2.48 after jumping over 25% on Thursday.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) declined 28.9% to close at $1.60. Senti Biosciences, last month, posted a Q2 loss of $0.86 per share.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 28.7% to close at $7.87.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) declined 27.8% to close at $17.92. NeuroBo Pharmaceuticals recently announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo.
    • Netcapital Inc. (NASDAQ:NCPL) fell 26.3% to close at $2.05. Netcapital recently announced revenue growth of 114% for first quarter.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 22.7% to close at $4.56.
    • FedEx Corporation (NYSE:FDX) fell 21.4% to close at $161.02 after the company issued preliminary Q1 earnings results. Keybanc and JP Morgan also downgraded the stock.
    • NCR Corporation (NYSE:NCR) shares declined 20.3% to close at $23.20 after the company announced it will separate into two independent, publicly traded companies – one focused on digital commerce, the other on ATMs.
    • D-Wave Quantum Inc. (NYSE:QBTS) fell 20.2% to settle at $6.64.
    • Midatech Pharma plc (NASDAQ:MTP) fell 20% to close at $0.5330.
    • Caladrius Biosciences, Inc. (NASDAQ:LSTA) dipped 20% to close at $5.00.
    • AMTD Digital Inc. (NYSE:HKD) fell 19.8% to close at $108.00 after tumbling around 29% on Thursday.
    • Alignment Healthcare, Inc. (NASDAQ:ALHC) dropped 19.5% to settle at $12.88 after the company announced a secondary offering.
    • Apexigen, Inc. (NASDAQ:APGN) declined 19.1% to close at $5.76. Apexigen recently announced the presentation of new data from a Phase 2 trial evaluating sotigalimab in combination with neoadjuvant chemoradiation for resectable esophageal and gastroesophageal junction cancers.
    • Ra Medical Systems, Inc. (NYSE:RMED) dipped 19.1% to settle at $0.1365.
    • PepGen Inc. (NASDAQ:PEPG) fell 18.9% to settle at $5.63.
    • PaxMedica, Inc. (NASDAQ:PXMD) fell 18.6% to settle at $3.16.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares fell 17.7% to close at $1.91. Heartbeam shares jumped over 85% on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) fell 17.6% to close at $10.80. Keybanc initiated coverage on Recursion Pharmaceuticals with an Overweight rating and announced a price target of $20.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) fell 17.5% to close at $0.5702.
    • 1847 Holdings LLC (NYSE:EFSH) dropped 17.5% to close at $2.0390.
    • Addentax Group Corp. (NASDAQ:ATXG) fell 17.2% to settle at $4.47.
    • Kensington Capital Acquisition Corp. IV (NYSE:AMPX) fell 17% to close at $8.30 on Friday after gaining 11% on Thursday.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) dipped 14.9% to close at $5.08.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) declined 14% to close at $4.04.
    • C4 Therapeutics, Inc. (NASDAQ:CCCC) dipped 13.6% to close at $9.82.
    • Ainos, Inc. (NASDAQ:AIMD) fell 13.4% to close at $1.61.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) dropped 13.4% to settle at $8.60.
    • Onion Global Limited (NYSE:OG) declined 13.1% to close at $0.4390.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) fell 12.4% to close at $0.9018.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) dropped 11.9% to close at $36.55.
    • WestRock Company (NYSE:WRK) declined 11.5% to close at $34.15. Jefferies maintained WestRock with a Hold and lowered the price target from $45 to $42.
    • Athersys, Inc. (NASDAQ:ATHX) fell 11.4% to close at $1.95.
    • International Paper Company (NYSE:IP) dropped 11.2% to close at $35.23 after Jefferies downgraded the stock from Hold to Underperform and lowered its price target from $40 to $31.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) dropped 11.1% to close at $11.37.
    • Carvana Co. (NYSE:CVNA) declined 11.1% to settle at $32.92 amid negative economic sentiment. A slowdown in the economy could cause consumers to cut back on spending, which would negatively impact the auto market.
    • Packaging Corporation of America (NYSE:PKG) declined 11% to close at $118.07.
    • Vipshop Holdings Limited (NYSE:VIPS) dropped 10.9% to close at $9.41.
    • Natura &Co Holding S.A. (NYSE:NTCO) fell 10.3% to close at $5.68.
    • Roblox Corporation (NYSE:RBLX) dropped 9.2% to close at $39.50 on continued downward momentum following the company's Investor Day event. Also, LightShed partner Brandon Ross tweeted the company's booking growth in August decelerated month over month. Needham maintained Roblox with a Buy and lowered the price target from $55 to $53.
    • Avis Budget Group, Inc. (NASDAQ:CAR) dipped 8.9% to close at $147.30.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) fell 8.9% to settle at $10.25.
    • Adicet Bio, Inc. (NASDAQ:ACET) fell 8% to close at $15.76. Adicet Bio, last month, posted a Q2 loss of $0.56 per share.
    • UroGen Pharma Ltd. (NASDAQ:URGN) dipped 7.3% to close at $8.72. UroGen Pharma, last month, posted a Q2 loss of $1.18 per share.
    • United Parcel Service, Inc. (NYSE:UPS) shares fell 4.5% to close at $176.71 after FedEx said its fiscal first-quarter results were adversely impacted by global volume softness that accelerated in the final weeks of the quarter.
    • Amazon.com, Inc. (NASDAQ:AMZN) fell 2.2% to close at $123.53 amid overall market weakness following bearish economic comments from FedEx.
    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ACET
    $ADTX
    $AIMD

    CompanyDatePrice TargetRatingAnalyst
    Vipshop Holdings Limited
    $VIPS
    2/27/2026$22.00Neutral → Buy
    Nomura
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$55.00Outperform → Market Perform
    Northland Capital
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$54.00Sell → Neutral
    B. Riley Securities
    FedEx Corporation
    $FDX
    2/25/2026$335.00Hold → Reduce
    HSBC Securities
    Amazon.com Inc.
    $AMZN
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    Foghorn Therapeutics Inc.
    $FHTX
    2/17/2026$12.00Buy
    Jefferies
    FedEx Corporation
    $FDX
    2/13/2026$313.00 → $383.00Buy
    TD Cowen
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    More analyst ratings

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Director Mastantuono Gina bought $950 worth of shares (22 units at $43.20) and sold $790 worth of shares (22 units at $35.90) (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/13/26 5:07:32 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Director Connor Christopher M bought $1,009,250 worth of shares (25,000 units at $40.37) (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/2/26 5:30:10 PM ET
    $IP
    Paper
    Basic Materials

    $AAOI
    $ACET
    $ADTX
    $AIMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug LEVOFLOXACIN (SUPPL-11) with active ingredient LEVOFLOXACIN has changed to 'Approval' on 09/20/2024. Application Category: ANDA, Application Number: 205222, Application Classification: Labeling

    9/24/24 4:39:48 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug MYCOPHENOLATE MOFETIL (SUPPL-7) with active ingredient MYCOPHENOLATE MOFETIL has changed to 'Approval' on 08/13/2024. Application Category: ANDA, Application Number: 214525, Application Classification: REMS

    8/15/24 4:43:42 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vipshop upgraded by Nomura with a new price target

    Nomura upgraded Vipshop from Neutral to Buy and set a new price target of $22.00

    2/27/26 9:00:21 AM ET
    $VIPS
    Catalog/Specialty Distribution
    Consumer Discretionary

    Applied Optoelectronics downgraded by Northland Capital with a new price target

    Northland Capital downgraded Applied Optoelectronics from Outperform to Market Perform and set a new price target of $55.00

    2/27/26 8:26:41 AM ET
    $AAOI
    Semiconductors
    Technology

    Applied Optoelectronics upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded Applied Optoelectronics from Sell to Neutral and set a new price target of $54.00

    2/27/26 8:19:46 AM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $ACET
    $ADTX
    $AIMD
    SEC Filings

    View All

    iBio Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - iBio, Inc. (0001420720) (Filer)

    2/27/26 4:49:58 PM ET
    $IBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Applied Optoelectronics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - APPLIED OPTOELECTRONICS, INC. (0001158114) (Filer)

    2/27/26 4:40:50 PM ET
    $AAOI
    Semiconductors
    Technology

    SEC Form 10-K filed by International Paper Company

    10-K - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Filer)

    2/27/26 4:25:22 PM ET
    $IP
    Paper
    Basic Materials

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Leadership Updates

    Live Leadership Updates

    View All

    Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that Ryan Maynard will join the company as Chief Financial Officer (CFO) on February 23, 2026. Mr. Maynard joins Foghorn with over 25 years of executive experience driving financial strategy, capital markets execution, and operational performance across public and private biopharmaceutical companies. "I am delighted to welcome Ryan to Foghorn as our new CFO as we continue to advance our first-in-class pipeline," said Adrian Gottschalk, Pres

    2/23/26 7:00:00 AM ET
    $FHTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Financials

    Live finance-specific insights

    View All

    Gogo Announces Fourth Quarter and Full Year 2025 Results

    Total Q4 Revenue of $230.6 million, up 67% Year-over-Year; Service Revenue of $191.9 million, up 61% Year-over-Year  Full Year Results at High End of 2025 Guidance Range for Revenue, Adjusted EBITDA and Free Cash Flow Gogo Galileo and 5G Expected to Ramp in 2026 Company Provides 2026 Financial Guidance BROOMFIELD, Colo., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Gogo Inc. (NASDAQ:GOGO) ("Gogo" or the "Company"), a leading global provider of broadband connectivity services for the business and military/government aviation markets, today announced its financial results for the quarter ended December 31, 2025 and full year results for 2025. Fourth quarter and full year 2025 financial results fo

    2/27/26 7:00:00 AM ET
    $GOGO
    Telecommunications Equipment
    Consumer Discretionary

    Applied Optoelectronics Reports Fourth Quarter and Full Year 2025 Results

    SUGAR LAND, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power the internet, today announced financial results for its fourth quarter and full year ended December 31, 2025. "We are pleased to deliver record fourth quarter results that were in line with or better than our expectations, and which capped off the strongest year in our company's history," said Dr. Thompson Lin, AOI's Founder, President and Chief Executive Officer. "Our results were driven by broad-based demand in both our CATV and datacenter businesses. We have considerable momentum entering 2026, and we b

    2/26/26 4:10:00 PM ET
    $AAOI
    Semiconductors
    Technology

    SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

    SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today reported its financial results for the fourth quarter and full year 2025. "As traditional software faces massive AI disruption, businesses are looking to partner with AI natives that can help them achieve success in a new era. This is creating strong tailwinds for SoundHound," said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. "Our results speak for themselves. All key profit metrics were up and in the last quarter we closed a record number of customer deals as we capitalized on the surge in demand for enterprise-grade AI." Financial Hig

    2/26/26 4:06:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, with summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on the Company's investor relations w

    2/27/26 4:25:00 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Caribou Biosciences Inc.

    SC 13D/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    12/6/24 4:06:56 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp exercised 200 in-the-money shares at a strike of $150.00 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/27/26 9:30:13 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Director Robinson James A. Jr. converted options into 2,000 units of ordinary shares, increasing direct ownership by 100% to 4,000 units (SEC Form 4)

    4 - UroGen Pharma Ltd. (0001668243) (Issuer)

    2/27/26 4:44:12 PM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Technology Officer Kelly Timothy P sold $12,020 worth of shares (6,228 units at $1.93), decreasing direct ownership by 8% to 73,125 units (SEC Form 4)

    4 - Caribou Biosciences, Inc. (0001619856) (Issuer)

    2/27/26 4:01:13 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care